Trial Profile
A study evaluating efficacy, safety and pharmacokinetics of of OPT-80 in patients with Clostridium difficile Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2018
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary)
- Indications Clostridium difficile infections; Diarrhoea
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use